WNT5B and bone sarcoma: In contrast, among noncanonical Wnt ligands, the expression of Wnt5a, Wnt5b and Wnt16 was either decreased or lost in bone sarcoma cells; however, Wnt6, Wnt7b, and Wnt11 were remarkably increased in bone sarcoma cells.